Edward Holson, Director of Medicinal Chemistry, Stanley Center for Psychiatric Research The Broad Institute of MIT and Harvard, Cambridge, MA: "HDACs in memory and cognition: Development of isoform selective inhibitors with improved CNS drug properties"

James Rusche, Senior Vice President of Research and Development, RepliGen Corporation, Waltham, MA and
Vincent Jacques, Senior Director of Preclinical Development, RepliGen Corporation, Waltham, MA: "HDAC Inhibitors for CNS Diseases: Challenges in Selectivity and Pharmacology"